Christopher K. Murray, SVP, TECHNICAL OPERATIONS at Blueprint Medicines Corp (BPMC), sold 2,634 shares at $60.27 ($157K) on 2022-03-03, disclosed to the SEC on 2022-03-08.
Open-market sale of $157k BPMC by SVP, TECHNICAL OPERATIONS. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.27 | 1,066 | $64K | 41.0% |
| 2 | $60.27 | 1,066 | $64K | 41.0% |
| 3 | $56.19 | 502 | $28K | 18.0% |
| Total | $59.49 avg | 2,634 | $157K | 100% |
| Filing → |
| BPMC | SELL | 2024-03-01 | $500K | — | Filing → |
| BPMC | SELL | 2023-12-11 | $375K | — | Filing → |
| BPMC | SELL | 2023-12-06 | $43K | — | Filing → |